dilemmas neon a to lo gist 2
TRANSCRIPT
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 1/45
Dilemmas of a Neonatologist
Tom Stiris; MD, Phd, NICU, Oslo University Hospital, Norway
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 2/45
Modern medicine has evolved rapidly the last
decade.
This has directed the neonatologist intodifferent scenarios of dilemmas.
Along with technological developments inneonatology there has been a continuingdebate about ethical issues
Dilemmas of a Neonatologist
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 3/45
Dilemmas of a Neonatologist
To be or not to be that is
the question
William Shakespeare
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 4/45
To start or not to start
To end or not to end
?
Dilemmas of a Neonatologist
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 5/45
When to start, when to withhold ?
Treatment, do we do more harm than good? When is enough-enough?
Dilemmas of a Neonatologist
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 6/45
A number of ethical theories and principles
are relevant.
Ethical considerations
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 7/45
“All human life has worth and therefore it is wrong to take steps to end a person's life,directly or indirectly, no matter what the quality
of that life.”
Sanctity of Life Doctrine
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 8/45
Should life be preserved at all costs?
Is there no place for consideration of quality
of life?
Challenged
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 9/45
This distinction argues that there is a
difference between actively killing someoneand refraining from an action that may saveor preserve that person's life
Acts /omissions of distinction
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 10/45
A translation of this would imply thatwithholding/withdrawing treatment isregarded as legal and regarded differentlythan actively killing.
This would be an important point in thediscussion between withholding/ withdrawingtreatment and euthanasia.
In many countries withholding/withdrawingtreatment would be accepted legally, howevereuthanasia will not be acceptable by the samelegal system.
Acts /omissions of distinction
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 11/45
The doctrine of double effect argues that
there is a moral distinction between actingwith the intention to bring about a person'sdeath and performing an act where death is aforeseen but unintended consequence.
Doctrine of Double Effect
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 12/45
This is an important ethical principle veryoften used in palliative care and end of lifedecisions.
An example is the use of morphine to easepain and discomfort although we know thatin the end it may have fatal effect on the
respiration
Doctrine of Double Effect
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 13/45
Guidelines recently published by theNorwegian authorities it states:◦ When life prolonging treatment has been
withdrawn, palliative treatment should be continued
or augmented.◦ The patient (neonate) must have adequate pain
relieve even if it cannot exclude hastening death
Doctrine of Double Effect
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 14/45
The principle for respect for autonomy
acknowledges the right of a patient to havecontrol over his or her own life, includingdecisions about how his/her life should end.
Respect for autonomy
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 15/45
For the neonate it would be decision in proxy,
meaning someone else will act in their bestinterest to make these decisions.
In most instances it would be the Parents,however health workers may also act in proxy
Respect for autonomy
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 16/45
Is it so that a parent can demand treatmentwhere death is inevitable.
Deny a decision to stop treatment whencontinued treatment just prolong the deathproses.
Can parents deny treatment for their infantsor demand respirators turned off
Respect for autonomy
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 17/45
A common belief is that a parent do NOT
have an absolute right to demand treatment,nor prolongation.
Respect for autonomy
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 18/45
An important question is whether the parent
always acts in the best interest of their childeven although they do belief so
Respect for autonomy
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 19/45
The duty of beneficence, that is to act in a
way that benefits the patient, is an importantethical principle in health care.
A duty to act in the patient's bestinterest-Beneficence
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 20/45
The concept of nonmaleficence - anobligation not to inflict harm intentionally
How much harm caused by the treatmentneeds to be considered, as does thequestion of whether death itself is always aharm.
Many medical treatments may have harmful
side effects but save or improve lives.
A duty not to harm-Nonmaleficence
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 21/45
Legal considerations
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 22/45
Common dilemmas as in “end of lifedecision”
However◦ These situations may be matter of there and then
decisions.
◦ The neonatologist will be very alone in the decisionmaking.
Initiation, when to start, when towithhold
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 23/45
The intention is to save the newborn infant‟s
life and minimize morbidity.
Initiation, when to start, when towithhold
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 24/45
In some circumstances no effort is made to
save the life of the newborn◦ Providing peaceful death for the child and
emotional support for the parents
Initiation, when to start, when to
withhold
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 25/45
Is this approach never ethically justified ?
The parents should decide ?
In some settings resuscitation should not beattempted ?
Ethically justified?
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 26/45
The AAP Committee on Fetus and newbornemphasize the importance of basing
decisions on an assessment of the child‟sbest interest.◦ An intervention is generally considered to be in a
patient‟s best interest if the overall benefit to the
patient outweighs the overall burden to the patient .
Ethical?
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 27/45
A duty to act in the patient's bestinterest-Beneficence
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 28/45
GA – when is young too young ?
Congenital abnormalities ?
Chromosomal abnormalities ?
Possible clinical settings
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 29/45
If there is a reasonable chance it will provide
the patient with an overall net benefit anddoes not represent an injustice or unfair
burden to the infant
To start
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 30/45
What unfair burden to the infant implies isdiscussable:◦ But If death is inevitable even if treatment is started
◦ That the prospect to survive without majorhandicaps is extremely poor
It would be regarded as an unfair burden
To start
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 31/45
Based on Relevant data
◦ Predicted survival
◦ Morbidity
Application of ethical reasoning and analysesof these data
To start
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 32/45
Which data are available ?
Are they valid ?
Are there any consensus based on theavailable data ?
Do they apply to our clinical setting ?
Are the data relevant ?
Application of available data
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 33/45
Previously neonatology was advancing so fastthat outcome data reported as “new” werealready out of date.
However, for the last decade there has been amore steady state in the development inneonatology, thus outcome for prematureinfants borne in 2000, is still valid for infantsborn in 2011.
Application of available data: Are outcomedata relevant in today „s clinical setting.
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 34/45
GA used as guidelines◦ Based on outcome data
GA – when is young too young
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 35/45
The UK, Nuffield Counsel on Bioethicspublished guidelines in 2006.
Resuscitation should not be standard practiceat 22 completed weeks, unless requested in
written by the parents
Parents should be given a choice at 23completed weeks
And possibly at 24, but at 25 resuscitationshould be done.
GA – when is young too young
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 36/45
Norway have similar consensus, but put 23
completed weeks in their recommendation,others have 24 completed weeks
GA – when is young too young
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 37/45
How certain is it that the GA is correct
How to validate outcome◦ Quality of life measurements?
GA – when is young too young
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 38/45
Choice of treatment, do we domore harm than good
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 39/45
New treatments have been initiated without
good evidence based foundations.
Unexpected side-effects, despite clinicaltrials
Off-label drugs
Choice of treatment, do we do moreharm than good
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 40/45
“ Organ targeted” approach:
◦ Catch-up growth or beneficial under-nutrition
◦ Perceptive hypercapnia – good or bad?
◦ “high” vs “low” oxygen approach
Choice of treatment, do we domore harm than good
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 41/45
An important question that needs to beconsidered is whether the neonatologist‟sobligation is to preserve life for whatevercosts?
Is there any obligations to provide lifesustaining treatment if the benefits of thattreatment no longer outweigh the burden tothe patient?
Do we prolong life or just delay death?
Withdrawal of treatment, end of lifedecisions
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 42/45
Who decides◦ Doctor ?
◦ Parents/Family ?
◦ Child ?
◦ Nurses ?◦ Others ?
Withdrawal of treatment, end of life
decisions
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 43/45
Guidelines/laws
Communication “health workers/parent”
Aim “joint” decision Ethical committees
Outside “second opinions”
Withdrawal of treatment, end of life
decisions
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 44/45
Benevolent Injustice; A Neonatal Dilemma; Brenda Barnum; Advances in Neonatal Care • Vol. 9, 3; 132-136,2009
BMA Ethics: End-of-life decisions Views of the BMA, August; 2009
Consent and end of life decisions, John Harris; J Med Ethics ;29:10–15; 2003
Dignified Death for Severely Impaired Infants: Beyond the Best-Interest Standard; Pedro Weisleder, 22: 737 J
Child Neurol; 2007
End-of-life decision before and after birth: changing ethical considerations; Andrew B. Pinter; Journal of Pediatric Surgery ; 43, 430–436; 2008
The ethics of delivery-rooms resuscitation. Byrne S, Szyld E, Kattwinkel J. Seminars in fetal and neonatalMedicine,13:440-447, 2008
Ethics in Neonatal Neurology: When is Enough, Enough? Eric Racine, Michael I. Shevell; Pediatr Neurol ;40:147-155.2009
Principles of Biomedical ethics. Beauchamp TL, Childress JF. New York, NY, Oxford University Press (ed.5), 225-
282, 2001 Moral dilemmas in neonatology as experienced by health care practitioners: A qualitative approach; Florence J.
van Zuuren, Eeke van Manen; Medicine, Health Care and Philosophy; 9:339–347;2006
Moral Reflections on Neonatal Intensive Care; William Meadow and John Lantos, 123;595-597 Pediatrics; 2009
Parental Refusal of medical treatment for a newborn, John J Paris, Michael D Schreiber, Michael P Moreland.Theoretical Medicine and Bioethics, 28:427–441, 2007.
Resuscitation of extremely low gestational age infants: an Advisory Committee‟s Dilemmas, Daniel Batton, ActaPædiatrica ; 99, 810–811, 2010
The Ethics of Newborn Resuscitation Mark R. Mercurio; Semin Perinatol 33:354-363; 2009 Withholding and withdrawing of life sustaining treatment in the newborn; J Tripp, D McGregor; Arch Dis Child
Fetal Neonatal ;91:F67–F71; 2006
The neonatologist's dilemma: catch-up growth or beneficial undernutrition in very low birth weight infants-whatare optimal growth rates? Thureen PJ. J Pediatr Gastroenterol Nutr.;45 Suppl 3:S152-4., 2007
Beslutningsprosesser for begrensning av livsforlengende behandling hos alvorlig syke og døende; TheNorwegian Department of Health, 2009
Melanie P. McGraw and Jeffrey M. Perlman: Attitudes of Neonatologists Toward Delivery Room Management of Confirmed
Trisomy 18: Potential Factors Influencing a Changing Dynamic; 121;1106-1110 Pediatrics,2008
Acknowledgement/References
8/6/2019 Dilemmas Neon a to Lo Gist 2
http://slidepdf.com/reader/full/dilemmas-neon-a-to-lo-gist-2 45/45
Thank you